Lemaitre Vascular (LMAT) Deferred Taxes (2010 - 2013)
Lemaitre Vascular (LMAT) reported Deferred Taxes of $2.0 million for Q4 2013, up 48775.0% quarter-over-quarter from $4000.0 in Q1 2012.
Lemaitre Vascular (LMAT) Deferred Taxes (2010 - 2013) Analysis & Trends
Lemaitre Vascular (LMAT) has 3 years of Deferred Taxes data on file, last reported at $2.0 million in Q4 2013.
- Deferred Taxes for Q4 2013 came in at $2.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2013 was -$286000.0 (changed N/A YoY), and the FY2025 annual result was $1.9 million, up 623.14% from the prior year.
- Deferred Taxes rose to $2.0 million in Q4 2013 per LMAT's latest filing, from $4000.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $2.0 million in Q4 2013 and troughed at -$2.3 million in Q4 2010.
- A 3-year average of -$71500.0 and a median of $49000.0 in 2010 frame the typical range for Deferred Taxes.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -339.30 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -73.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 37.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -41.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 43.50 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 40.64 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 29.00 Mn |
| 10 | Lemaitre Vascular | 2.12 Bn | 1.75 Bn | 48.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 1.96 Mn |
| Mar 31, 2012 | 4,000.00 |
| Dec 31, 2010 | -2.34 Mn |
| Sep 30, 2010 | 94,000.00 |